U.S. stocks closed rallied on Friday, with the Nasdaq Composite (COMP:IND) securing another back-to-back record, even as ...

A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

A legacy ranch in Jackson Hole, WY, has come onto the market, with records showing it is owned by former Eli Lilly exec Dr. Jan Lundberg.

Lupin introduces generic Glucagon for Injection USP in the US market. Bioequivalent to Eli Lilly's, used for hypoglycemia ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

Earnings season slows this week, with investors waiting on NVIDIA’s earnings on August 27. Retail sales and inflation ...

Global pharma major Lupin Limited (Lupin) announced the launch of glucagon for injection USP, 1mg/vial packaged in an emergency kit in the United States. Glucagon for injection USP, 1mg/vial packaged ...

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...

There's been an all-out push by the drug regulators and media to get every adult and child on Ozempic, a drug which causes temporary weight loss and harms the majority of recipients. Here, two leading ...

The drug category has an estimated annual sale of $122 million in the US. Shares of Lupin were marginally higher in the ...

Buck up, baby boomers. Sixty may not be the new 40, but 80 could soon be the new 60. A trove of new Alzheimer’s research ...